Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants-Reference-Cited by-同舟云学术

Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants

Published:2017-11-30 Issue:2 Volume:34 Page:285-295
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Gilligan Adrienne M.¹,Franchino-Elder Jessica²,Song Xue¹,Wang Cheng²,Henriques Caroline¹,Sainski-Nguyen Amy¹,Wilson Kathleen¹,Smith David M.¹,Sander Stephen²

Affiliation:

1. Truven Health Analytics, an IBM Company, Cambridge, MA, USA;

2. Boehringer-Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1409425

Reference52 articles.

1. National Heart, Lung, and Blood Institute. What is atrial fibrillation? U.S. Department of Health and Human Services 2015. Available at: http://www.nhlbi.nih.gov/health/health-topics/topics/af. [Last accessed Q2 15 October 2015]

2. Heart Disease and Stroke Statistics—2015 Update

3. Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

4. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cost of Atrial Fibrillation: A Systematic Review;Value in Health;2024-04

2. Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study;Journal of Cardiovascular Pharmacology and Therapeutics;2024-01

3. Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France;The European Journal of Health Economics;2022-08-28

4. Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event;Advances in Therapy;2020-08-06

5. Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges;Journal of the American Heart Association;2020-07-07